CodeMap®  		150 North Wacker Drive
Suite 2360
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:

Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2025
2024
QW Tests

Physician Fee Schedule

2025
2024

OPPS Fee Schedule

2025-July
2025-April

ASC Fee Schedule

2025-July
2025-April

APC Codes

2025-July
2025-April

DRG Codes

2025
2024

ASP Drug Pricing Files

2025-July
2025-April


CMS Transmittals



.

ICD-10 Code or Description Search:
Injury, poisoning and certain other consequences of external causes -Back to Parent Categories

Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified-Back to Sub Category

ICD-10 CodeDescription
T45.0X1APoisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
T45.0X1DPoisoning by antiallergic and antiemetic drugs, accidental (unintentional), subsequent encounter
T45.0X1SPoisoning by antiallergic and antiemetic drugs, accidental (unintentional), sequela
T45.0X2APoisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
T45.0X2DPoisoning by antiallergic and antiemetic drugs, intentional self-harm, subsequent encounter
T45.0X2SPoisoning by antiallergic and antiemetic drugs, intentional self-harm, sequela
T45.0X3APoisoning by antiallergic and antiemetic drugs, assault, initial encounter
T45.0X3DPoisoning by antiallergic and antiemetic drugs, assault, subsequent encounter
T45.0X3SPoisoning by antiallergic and antiemetic drugs, assault, sequela
T45.0X4APoisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
T45.0X4DPoisoning by antiallergic and antiemetic drugs, undetermined, subsequent encounter
T45.0X4SPoisoning by antiallergic and antiemetic drugs, undetermined, sequela
T45.0X5AAdverse effect of antiallergic and antiemetic drugs, initial encounter
T45.0X5DAdverse effect of antiallergic and antiemetic drugs, subsequent encounter
T45.0X5SAdverse effect of antiallergic and antiemetic drugs, sequela
T45.0X6AUnderdosing of antiallergic and antiemetic drugs, initial encounter
T45.0X6DUnderdosing of antiallergic and antiemetic drugs, subsequent encounter
T45.0X6SUnderdosing of antiallergic and antiemetic drugs, sequela
T45.1X1APoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
T45.1X1DPoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter
T45.1X1SPoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela
T45.1X2APoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
T45.1X2DPoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter
T45.1X2SPoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela
T45.1X3APoisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
T45.1X3DPoisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter
T45.1X3SPoisoning by antineoplastic and immunosuppressive drugs, assault, sequela
T45.1X4APoisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
T45.1X4DPoisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter
T45.1X4SPoisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela
T45.1X5AAdverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5DAdverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X5SAdverse effect of antineoplastic and immunosuppressive drugs, sequela
T45.1X6AUnderdosing of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X6DUnderdosing of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X6SUnderdosing of antineoplastic and immunosuppressive drugs, sequela
T45.2X1APoisoning by vitamins, accidental (unintentional), initial encounter
T45.2X1DPoisoning by vitamins, accidental (unintentional), subsequent encounter
T45.2X1SPoisoning by vitamins, accidental (unintentional), sequela
T45.2X2APoisoning by vitamins, intentional self-harm, initial encounter
T45.2X2DPoisoning by vitamins, intentional self-harm, subsequent encounter
T45.2X2SPoisoning by vitamins, intentional self-harm, sequela
T45.2X3APoisoning by vitamins, assault, initial encounter
T45.2X3DPoisoning by vitamins, assault, subsequent encounter
T45.2X3SPoisoning by vitamins, assault, sequela
T45.2X4APoisoning by vitamins, undetermined, initial encounter
T45.2X4DPoisoning by vitamins, undetermined, subsequent encounter
T45.2X4SPoisoning by vitamins, undetermined, sequela
T45.2X5AAdverse effect of vitamins, initial encounter
T45.2X5DAdverse effect of vitamins, subsequent encounter
T45.2X5SAdverse effect of vitamins, sequela
T45.2X6AUnderdosing of vitamins, initial encounter
T45.2X6DUnderdosing of vitamins, subsequent encounter
T45.2X6SUnderdosing of vitamins, sequela
T45.3X1APoisoning by enzymes, accidental (unintentional), initial encounter
T45.3X1DPoisoning by enzymes, accidental (unintentional), subsequent encounter
T45.3X1SPoisoning by enzymes, accidental (unintentional), sequela
T45.3X2APoisoning by enzymes, intentional self-harm, initial encounter
T45.3X2DPoisoning by enzymes, intentional self-harm, subsequent encounter
T45.3X2SPoisoning by enzymes, intentional self-harm, sequela
T45.3X3APoisoning by enzymes, assault, initial encounter
T45.3X3DPoisoning by enzymes, assault, subsequent encounter
T45.3X3SPoisoning by enzymes, assault, sequela
T45.3X4APoisoning by enzymes, undetermined, initial encounter
T45.3X4DPoisoning by enzymes, undetermined, subsequent encounter
T45.3X4SPoisoning by enzymes, undetermined, sequela
T45.3X5AAdverse effect of enzymes, initial encounter
T45.3X5DAdverse effect of enzymes, subsequent encounter
T45.3X5SAdverse effect of enzymes, sequela
T45.3X6AUnderdosing of enzymes, initial encounter
T45.3X6DUnderdosing of enzymes, subsequent encounter
T45.3X6SUnderdosing of enzymes, sequela
T45.4X1APoisoning by iron and its compounds, accidental (unintentional), initial encounter
T45.4X1DPoisoning by iron and its compounds, accidental (unintentional), subsequent encounter
T45.4X1SPoisoning by iron and its compounds, accidental (unintentional), sequela
T45.4X2APoisoning by iron and its compounds, intentional self-harm, initial encounter
T45.4X2DPoisoning by iron and its compounds, intentional self-harm, subsequent encounter
T45.4X2SPoisoning by iron and its compounds, intentional self-harm, sequela
T45.4X3APoisoning by iron and its compounds, assault, initial encounter
T45.4X3DPoisoning by iron and its compounds, assault, subsequent encounter
T45.4X3SPoisoning by iron and its compounds, assault, sequela
T45.4X4APoisoning by iron and its compounds, undetermined, initial encounter
T45.4X4DPoisoning by iron and its compounds, undetermined, subsequent encounter
T45.4X4SPoisoning by iron and its compounds, undetermined, sequela
T45.4X5AAdverse effect of iron and its compounds, initial encounter
T45.4X5DAdverse effect of iron and its compounds, subsequent encounter
T45.4X5SAdverse effect of iron and its compounds, sequela
T45.4X6AUnderdosing of iron and its compounds, initial encounter
T45.4X6DUnderdosing of iron and its compounds, subsequent encounter
T45.4X6SUnderdosing of iron and its compounds, sequela
T45.511APoisoning by anticoagulants, accidental (unintentional), initial encounter
T45.511DPoisoning by anticoagulants, accidental (unintentional), subsequent encounter
T45.511SPoisoning by anticoagulants, accidental (unintentional), sequela
T45.512APoisoning by anticoagulants, intentional self-harm, initial encounter
T45.512DPoisoning by anticoagulants, intentional self-harm, subsequent encounter
T45.512SPoisoning by anticoagulants, intentional self-harm, sequela
T45.513APoisoning by anticoagulants, assault, initial encounter
T45.513DPoisoning by anticoagulants, assault, subsequent encounter
T45.513SPoisoning by anticoagulants, assault, sequela
T45.514APoisoning by anticoagulants, undetermined, initial encounter
T45.514DPoisoning by anticoagulants, undetermined, subsequent encounter
T45.514SPoisoning by anticoagulants, undetermined, sequela
T45.515AAdverse effect of anticoagulants, initial encounter
T45.515DAdverse effect of anticoagulants, subsequent encounter
T45.515SAdverse effect of anticoagulants, sequela
T45.516AUnderdosing of anticoagulants, initial encounter
T45.516DUnderdosing of anticoagulants, subsequent encounter
T45.516SUnderdosing of anticoagulants, sequela
T45.521APoisoning by antithrombotic drugs, accidental (unintentional), initial encounter
T45.521DPoisoning by antithrombotic drugs, accidental (unintentional), subsequent encounter
T45.521SPoisoning by antithrombotic drugs, accidental (unintentional), sequela
T45.522APoisoning by antithrombotic drugs, intentional self-harm, initial encounter
T45.522DPoisoning by antithrombotic drugs, intentional self-harm, subsequent encounter
T45.522SPoisoning by antithrombotic drugs, intentional self-harm, sequela
T45.523APoisoning by antithrombotic drugs, assault, initial encounter
T45.523DPoisoning by antithrombotic drugs, assault, subsequent encounter
T45.523SPoisoning by antithrombotic drugs, assault, sequela
T45.524APoisoning by antithrombotic drugs, undetermined, initial encounter
T45.524DPoisoning by antithrombotic drugs, undetermined, subsequent encounter
T45.524SPoisoning by antithrombotic drugs, undetermined, sequela
T45.525AAdverse effect of antithrombotic drugs, initial encounter
T45.525DAdverse effect of antithrombotic drugs, subsequent encounter
T45.525SAdverse effect of antithrombotic drugs, sequela
T45.526AUnderdosing of antithrombotic drugs, initial encounter
T45.526DUnderdosing of antithrombotic drugs, subsequent encounter
T45.526SUnderdosing of antithrombotic drugs, sequela
T45.601APoisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
T45.601DPoisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter
T45.601SPoisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), sequela
T45.602APoisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter
T45.602DPoisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter
T45.602SPoisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, sequela
T45.603APoisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter
T45.603DPoisoning by unspecified fibrinolysis-affecting drugs, assault, subsequent encounter
T45.603SPoisoning by unspecified fibrinolysis-affecting drugs, assault, sequela
T45.604APoisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter
T45.604DPoisoning by unspecified fibrinolysis-affecting drugs, undetermined, subsequent encounter
T45.604SPoisoning by unspecified fibrinolysis-affecting drugs, undetermined, sequela
T45.605AAdverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45.605DAdverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
T45.605SAdverse effect of unspecified fibrinolysis-affecting drugs, sequela
T45.606AUnderdosing of unspecified fibrinolysis-affecting drugs, initial encounter
T45.606DUnderdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter
T45.606SUnderdosing of unspecified fibrinolysis-affecting drugs, sequela
T45.611APoisoning by thrombolytic drug, accidental (unintentional), initial encounter
T45.611DPoisoning by thrombolytic drug, accidental (unintentional), subsequent encounter
T45.611SPoisoning by thrombolytic drug, accidental (unintentional), sequela
T45.612APoisoning by thrombolytic drug, intentional self-harm, initial encounter
T45.612DPoisoning by thrombolytic drug, intentional self-harm, subsequent encounter
T45.612SPoisoning by thrombolytic drug, intentional self-harm, sequela
T45.613APoisoning by thrombolytic drug, assault, initial encounter
T45.613DPoisoning by thrombolytic drug, assault, subsequent encounter
T45.613SPoisoning by thrombolytic drug, assault, sequela
T45.614APoisoning by thrombolytic drug, undetermined, initial encounter
T45.614DPoisoning by thrombolytic drug, undetermined, subsequent encounter
T45.614SPoisoning by thrombolytic drug, undetermined, sequela
T45.615AAdverse effect of thrombolytic drugs, initial encounter
T45.615DAdverse effect of thrombolytic drugs, subsequent encounter
T45.615SAdverse effect of thrombolytic drugs, sequela
T45.616AUnderdosing of thrombolytic drugs, initial encounter
T45.616DUnderdosing of thrombolytic drugs, subsequent encounter
T45.616SUnderdosing of thrombolytic drugs, sequela
T45.621APoisoning by hemostatic drug, accidental (unintentional), initial encounter
T45.621DPoisoning by hemostatic drug, accidental (unintentional), subsequent encounter
T45.621SPoisoning by hemostatic drug, accidental (unintentional), sequela
T45.622APoisoning by hemostatic drug, intentional self-harm, initial encounter
T45.622DPoisoning by hemostatic drug, intentional self-harm, subsequent encounter
T45.622SPoisoning by hemostatic drug, intentional self-harm, sequela
T45.623APoisoning by hemostatic drug, assault, initial encounter
T45.623DPoisoning by hemostatic drug, assault, subsequent encounter
T45.623SPoisoning by hemostatic drug, assault, sequela
T45.624APoisoning by hemostatic drug, undetermined, initial encounter
T45.624DPoisoning by hemostatic drug, undetermined, subsequent encounter
T45.624SPoisoning by hemostatic drug, undetermined, sequela
T45.625AAdverse effect of hemostatic drug, initial encounter
T45.625DAdverse effect of hemostatic drug, subsequent encounter
T45.625SAdverse effect of hemostatic drug, sequela
T45.626AUnderdosing of hemostatic drugs, initial encounter
T45.626DUnderdosing of hemostatic drugs, subsequent encounter
T45.626SUnderdosing of hemostatic drugs, sequela
T45.691APoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
T45.691DPoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter
T45.691SPoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela
T45.692APoisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter
T45.692DPoisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter
T45.692SPoisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela
T45.693APoisoning by other fibrinolysis-affecting drugs, assault, initial encounter
T45.693DPoisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter
T45.693SPoisoning by other fibrinolysis-affecting drugs, assault, sequela
T45.694APoisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
T45.694DPoisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter
T45.694SPoisoning by other fibrinolysis-affecting drugs, undetermined, sequela
T45.695AAdverse effect of other fibrinolysis-affecting drugs, initial encounter
T45.695DAdverse effect of other fibrinolysis-affecting drugs, subsequent encounter
T45.695SAdverse effect of other fibrinolysis-affecting drugs, sequela
T45.696AUnderdosing of other fibrinolysis-affecting drugs, initial encounter
T45.696DUnderdosing of other fibrinolysis-affecting drugs, subsequent encounter
T45.696SUnderdosing of other fibrinolysis-affecting drugs, sequela
T45.7X1APoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
T45.7X1DPoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter
T45.7X1SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela
T45.7X2APoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
T45.7X2DPoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter
T45.7X2SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela
T45.7X3APoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
T45.7X3DPoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter
T45.7X3SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela
T45.7X4APoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
T45.7X4DPoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter
T45.7X4SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela
T45.7X5AAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T45.7X5DAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
T45.7X5SAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
T45.7X6AUnderdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter
T45.7X6DUnderdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter
T45.7X6SUnderdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela
T45.8X1APoisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter
T45.8X1DPoisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter
T45.8X1SPoisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela
T45.8X2APoisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter
T45.8X2DPoisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter
T45.8X2SPoisoning by other primarily systemic and hematological agents, intentional self-harm, sequela
T45.8X3APoisoning by other primarily systemic and hematological agents, assault, initial encounter
T45.8X3DPoisoning by other primarily systemic and hematological agents, assault, subsequent encounter
T45.8X3SPoisoning by other primarily systemic and hematological agents, assault, sequela
T45.8X4APoisoning by other primarily systemic and hematological agents, undetermined, initial encounter
T45.8X4DPoisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter
T45.8X4SPoisoning by other primarily systemic and hematological agents, undetermined, sequela
T45.8X5AAdverse effect of other primarily systemic and hematological agents, initial encounter
T45.8X5DAdverse effect of other primarily systemic and hematological agents, subsequent encounter
T45.8X5SAdverse effect of other primarily systemic and hematological agents, sequela
T45.8X6AUnderdosing of other primarily systemic and hematological agents, initial encounter
T45.8X6DUnderdosing of other primarily systemic and hematological agents, subsequent encounter
T45.8X6SUnderdosing of other primarily systemic and hematological agents, sequela
T45.91XAPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter
T45.91XDPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter
T45.91XSPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela
T45.92XAPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter
T45.92XDPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter
T45.92XSPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela
T45.93XAPoisoning by unspecified primarily systemic and hematological agent, assault, initial encounter
T45.93XDPoisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter
T45.93XSPoisoning by unspecified primarily systemic and hematological agent, assault, sequela
T45.94XAPoisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
T45.94XDPoisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter
T45.94XSPoisoning by unspecified primarily systemic and hematological agent, undetermined, sequela
T45.95XAAdverse effect of unspecified primarily systemic and hematological agent, initial encounter
T45.95XDAdverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
T45.95XSAdverse effect of unspecified primarily systemic and hematological agent, sequela
T45.96XAUnderdosing of unspecified primarily systemic and hematological agent, initial encounter
T45.96XDUnderdosing of unspecified primarily systemic and hematological agent, subsequent encounter
T45.96XSUnderdosing of unspecified primarily systemic and hematological agent, sequela
T45.AX1APoisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounter
T45.AX1DPoisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter
T45.AX1SPoisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela
T45.AX2APoisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter
T45.AX2DPoisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter
T45.AX2SPoisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela
T45.AX3APoisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter
T45.AX3DPoisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter
T45.AX3SPoisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela
T45.AX4APoisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter
T45.AX4DPoisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter
T45.AX4SPoisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela
T45.AX5AAdverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter
T45.AX5DAdverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter
T45.AX5SAdverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela
T45.AX6AUnderdosing of immune checkpoint inhibitors and immunostimulant drugs, initial encounter
T45.AX6DUnderdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter
T45.AX6SUnderdosing of immune checkpoint inhibitors and immunostimulant drugs, sequela

CodeMap¨ is a Registered Trademark of Wheaton Partners, LLC.